Alerte De Sécurité sur ADVIA CHEMISTRY LIPASE REAGENTS (LIP) - Record 10345160626 - Model Kit of 4 x 160 tests: Reagent 1 (4 x 18 ml) / Reagent 2 (4 x 10 ml) - Lots 332463; 318706 (SCHEDULE OF DISTRIBUTION IN ANNEX)

Selon Agência Nacional de Vigilância Sanitária (ANVISA), ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Brazil qui a été fabriqué par SIEMENS HEALTHCARE DIAGNÓSTICOS S.A; SIEMENS HEALTHCARE DIAGNOSTICS, INC..

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • ID de l'événement
    1556
  • Date
    2015-04-24
  • Pays de l'événement
  • Source de l'événement
    ANVISA
  • URL de la source de l'événement
  • Notes / Alertes
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notes supplémentaires dans les données
    Company recommends: "* If the lipid panel (Triglycerides, Triglycerides, Triglycerides Concentrate, Cholesterol Concentrate and LDL Direct Cholesterol) is not being used together with the determination of Lipase in ADVIA Chemistry Systems, no action is required. * If the lipid panel is used in conjunction with Lipase in the ADVIA Chemistry Systems, Siemens recommends the following protocol to minimize the potential for falsely elevated Lipase assay results. a) Customers with two or more ADVIA Chemistry Systems shall perform the defined tests on the Lipid and Lipase panel in ADVIA Chemistry Systems separately. b) Clients with a single ADVIA Chemistry System and laboratories that choose to maintain lipase in the same system with the lipid panel should perform the automatic replication protocol described in the Letter to Customer to mitigate the possibility of obtaining falsely elevated Lipase test results. ".
  • Cause
    Siemens healthcare diagnostics has identified a high bias potential for the lipase assay in advia chemistry systems due to carryover of one or more of the following tests: triglycerides, triglycerides 2, triglycerides concentrate, cholesterol concentrate and ldl cholesterol direct. the potential carryover by these reagents can be mitigated from the design of designated contamination avoidance protocols. however, under certain circumstances, rare carryover incidents may occur.
  • Action
    The company is contacting its clients and providing guidance on the procedures to be followed (ANNEX) CHC Code 15-07

Manufacturer